LETTER TO THE EDITOR
Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action-more detailed kinetic studies are needed
Harel Dahari,
Corresponding Author
Harel Dahari
The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA
Correspondence
Harel Dahari, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, 2160 S. First Ave, Maywood, IL 60153, USA
Email: [email protected]
Search for more papers by this author Amir Shlomai,
Amir Shlomai
Beilinson Hospital, Department of Medicine D and The Liver Institute, Rabin Medical Center, Petah-Tikva and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this author Scott J. Cotler,
Scott J. Cotler
The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA
Search for more papers by this author
Harel Dahari,
Corresponding Author
Harel Dahari
The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA
Correspondence
Harel Dahari, The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, 2160 S. First Ave, Maywood, IL 60153, USA
Email: [email protected]
Search for more papers by this author Amir Shlomai,
Amir Shlomai
Beilinson Hospital, Department of Medicine D and The Liver Institute, Rabin Medical Center, Petah-Tikva and the Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Search for more papers by this author Scott J. Cotler,
Scott J. Cotler
The Program for Experimental & Theoretical Modeling, Division of Hepatology, Department of Medicine, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, USA
Search for more papers by this author
First published: 01 January 2021
No abstract is available for this article.
REFERENCES
- 1Gonçalves A, Lemenuel-Diot A, Cosson V, et al. What drives the dynamics of HBV RNA during treatment? J Viral Hepat. 2020. https://doi.org/10.1111/jvh.13425. [Epub ahead of print].
- 2Wang J, Shen T, Huang X, et al. Serum hepatitis B virus RNA is encapsidated pregenome RNA that may be associated with persistence of viral infection and rebound. J Hepatol. 2016; 65: 700-710.
- 3Janssen H, Hou J, Asselah T, et al. Efficacy and safety results of the phase 2 JNJ-56136379 JADE study in patients with chronic hepatitis B: interim week 24 data. J Hepatol. 2020; 73: S129-S130.
- 4Giersch K, Allweiss L, Volz T, Dandri M, Lutgehetmann M. Serum HBV pgRNA as a clinical marker for cccDNA activity. J Hepatol. 2017; 66: 460-462.
- 5Liu S, Liu Z, Li W, et al. Factors associated with the biphasic kinetics of serum HBV RNA in patients with HBeAg-positive chronic hepatitis B treated with nucleos(t)ide analogues. Aliment Pharmacol Ther. 2020; 52: 692-700.
